首页 正文

Targeting erythroid progenitor cells for cancer immunotherapy

{{output}}
Immunotherapy, especially immune checkpoint blockade therapy, represents a major milestone in the history of cancer therapy. However, the current response rate to immunotherapy among cancer patients must be improved; thus, new strategies for sensitizing patien... ...